SUVRETTA CAPITAL MANAGEMENT, LLC purchased 539.7% of their position (900K shares) of BENITEC BIOPHARMA INC. on the open market
Open‑market purchase worth $11.70M — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 3/28/2025ACC: 0000899140-25-000479
10% Owner
Since Apr 2024
+900K
Net shares
Net buyer
$11.70M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
900K acquired
Non-Derivative Transactions2
Common stock, par value $0.0001 per share
Indirect
Shares
+793.80K
Price / share
$13.00
Trade value
$10.32M
% of position
9.9%
3/26/2025
8M→8.79M
Common stock, par value $0.0001 per share
Indirect
Shares
+106.20K
Price / share
$13.00
Trade value
$1.38M
% of position
11.1%
3/26/2025
960.56K→1.07M
Total
Net shares
+900K
Net value
$11.70M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.0001 per share Indirect | 3/26/2025 | P · Purchase | +793.80K | $13.00 | $10.32M | 9.9% | 8M | 8.79M |
| Common stock, par value $0.0001 per share Indirect | 3/26/2025 | P · Purchase | +106.20K | $13.00 | $1.38M | 11.1% | 960.56K | 1.07M |
| Total | +900K | $11.70M | ||||||
Derivative Transactions0
No derivative transactions reported